Mark Lodge

1.2k total citations
17 papers, 858 citations indexed

About

Mark Lodge is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark Lodge has authored 17 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark Lodge's work include Global Cancer Incidence and Screening (3 papers), Advances in Oncology and Radiotherapy (3 papers) and Radiation Detection and Scintillator Technologies (2 papers). Mark Lodge is often cited by papers focused on Global Cancer Incidence and Screening (3 papers), Advances in Oncology and Radiotherapy (3 papers) and Radiation Detection and Scintillator Technologies (2 papers). Mark Lodge collaborates with scholars based in United Kingdom, United States and Netherlands. Mark Lodge's co-authors include G. Herbert Fowler, David Mant, C Silagy, Michael Brada, Madelon Pijls-Johannesma, S. Ashley, Peter Goldstraw, Francesca Soldà, Dirk De Ruysscher and Alastair J. Munro and has published in prestigious journals such as The Lancet, The Lancet Oncology and Cochrane Database of Systematic Reviews.

In The Last Decade

Mark Lodge

17 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Lodge United Kingdom 10 336 274 199 144 117 17 858
Katherine Harrison United States 13 252 0.8× 109 0.4× 31 0.2× 386 2.7× 44 0.4× 32 871
Anthony Flynn United States 10 345 1.0× 59 0.2× 205 1.0× 88 0.6× 35 0.3× 33 733
Will Jackson United States 24 806 2.4× 85 0.3× 310 1.6× 289 2.0× 85 0.7× 156 1.7k
Mark Deffebach United States 17 942 2.8× 189 0.7× 32 0.2× 204 1.4× 73 0.6× 36 1.5k
Jason Wang United States 16 106 0.3× 150 0.5× 22 0.1× 95 0.7× 213 1.8× 46 1.2k
Barry S. Berman United States 9 302 0.9× 74 0.3× 74 0.4× 39 0.3× 234 2.0× 12 1.3k
Takeshi Imaizumi Japan 14 128 0.4× 84 0.3× 26 0.1× 87 0.6× 85 0.7× 26 529
N. Pauwels Belgium 20 214 0.6× 126 0.5× 44 0.2× 31 0.2× 89 0.8× 59 1.0k
Dale S. Hardy United States 18 262 0.8× 162 0.6× 28 0.1× 148 1.0× 262 2.2× 27 995
Rachel McDonald Canada 24 425 1.3× 216 0.8× 68 0.3× 113 0.8× 162 1.4× 67 1.5k

Countries citing papers authored by Mark Lodge

Since Specialization
Citations

This map shows the geographic impact of Mark Lodge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lodge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lodge more than expected).

Fields of papers citing papers by Mark Lodge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lodge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lodge. The network helps show where Mark Lodge may publish in the future.

Co-authorship network of co-authors of Mark Lodge

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Lodge. A scholar is included among the top collaborators of Mark Lodge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Lodge. Mark Lodge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lodge, Mark, et al.. (2024). The Association between Home Health Nursing and 30-Day Hospital Readmission after Tracheostomy in Children. Home Healthcare Now. 42(6). 323–330. 1 indexed citations
2.
Downing, Julia, Gülcan Bağçıvan, Kathryn Burns, et al.. (2023). Celebrating oncology nursing: from adversity to opportunity. The Global Power of Oncology Nursing Conference held virtually on the 15th November 2022. ecancermedicalscience. 17. 1507–1507. 1 indexed citations
3.
Stanway, Susannah, Mark Lodge, Richard Sullivan, et al.. (2021). The UK's contribution to cancer control in low-income and middle-income countries. The Lancet Oncology. 22(9). e410–e418. 13 indexed citations
4.
Zubizarreta, Eduardo, Mark Lodge, May Abdel–Wahab, & Alfredo Polo. (2018). Cervical Cancer in the Commonwealth: Collective Action. Journal of Global Oncology. 4(Supplement 2). 153s–153s. 1 indexed citations
5.
Soldà, Francesca, et al.. (2013). Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; Systematic review and comparison with a surgical cohort. Radiotherapy and Oncology. 109(1). 1–7. 138 indexed citations
6.
Miller, Robert C., Mark Lodge, M. Hassan Murad, & Bleddyn Jones. (2013). Controversies in Clinical Trials in Proton Radiotherapy: The Present and the Future. Seminars in Radiation Oncology. 23(2). 127–133. 13 indexed citations
7.
Ruysscher, Dirk De, Mark Lodge, Bleddyn Jones, et al.. (2012). Charged particles in radiotherapy: A 5-year update of a systematic review. Radiotherapy and Oncology. 103(1). 5–7. 78 indexed citations
8.
Lodge, Mark. (2011). Conducting a systematic review: Finding the evidence. Journal of Evidence-Based Medicine. 4(2). 135–139. 1 indexed citations
9.
Lodge, Mark & Marilys Corbex. (2011). Establishing an evidence-base for breast cancer control in developing countries. The Breast. 20. S65–S69. 17 indexed citations
10.
Lodge, Mark. (2010). And then there were four: more countries beat guinea worm disease. BMJ. 340(jan26 2). c496–c496. 2 indexed citations
11.
Fedorowicz, Zbys, et al.. (2008). Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases. Cochrane Database of Systematic Reviews. CD006039–CD006039. 42 indexed citations
12.
Lodge, Mark, Madelon Pijls-Johannesma, Lisa Stirk, et al.. (2007). A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer. Radiotherapy and Oncology. 83(2). 110–122. 98 indexed citations
13.
Williams, Cathy, Susan J Brunskill, Doug Altman, et al.. (2006). Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy. Health Technology Assessment. 10(34). iii–iv, ix. 70 indexed citations
14.
Lodge, Mark, et al.. (2005). Organisation of a proposed Cochrane Diet and Nutrition Field. European Journal of Clinical Nutrition. 59(S1). S162–S166. 3 indexed citations
15.
Silagy, Christopher, et al.. (1997). A meta‐analysis of the effectiveness of acupuncture in smoking cessation. Drug and Alcohol Review. 16(1). 33–40. 20 indexed citations
16.
Williams, Chris, Mark Lodge, & Vivien Bramwell. (1997). Cancer reviews need to be systematic if they are to be reliable. European Journal of Cancer. 33. S128–S129. 1 indexed citations
17.
Silagy, C, David Mant, G. Herbert Fowler, & Mark Lodge. (1994). Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. The Lancet. 343(8890). 139–142. 359 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026